Discuss your research with your peers
Would you like to react to this message? Create an account in a few clicks or log in to continue.

Morpholino-peptide conjugates for DMD - in vitro predicts in vivo

Go down

Morpholino-peptide conjugates for DMD - in vitro predicts in vivo Empty Morpholino-peptide conjugates for DMD - in vitro predicts in vivo

Post  Jon Moulton Thu Mar 18, 2010 11:44 am

Wang Q, Yin H, Camelliti P, Betts C, Moulton H, Lee H, Saleh AF, Gait MJ, Wood MJ. In vitro evaluation of novel antisense oligonucleotides is predictive of in vivo exon skipping activity for Duchenne muscular dystrophy. J Gene Med. 2010 Mar 16. [Epub ahead of print]
Jon Moulton
Jon Moulton

Posts : 5721
Join date : 2010-03-12
Age : 62
Location : Philomath, Oregon, USA

http://www.gene-tools.com

Back to top Go down

Back to top

- Similar topics
» Quantitative correlation of in vivo properties with in vitro assay results - the in vitro binding of a biotin-DNA analog modifier with streptavidin predicts the in vivo avidin-induced clearability of the analog-modified antibody
» Quantitative Correlation of in Vivo Properties with in Vitro Assay Results: The in Vitro Binding of a Biotin-DNA Analogue Modifier with Streptavidin Predicts the in Vivo Avidin-Induced Clearability of the Analogue-Modified Antibody
» Peptide-conjugated phosphorodiamidate morpholino oligomer (PPMO) restores carbapenem susceptibility to NDM-1-positive pathogens in vitro and in vivo
» Context Dependent Effects of Chimeric Peptide Morpholino Conjugates Contribute to Dystrophin Exon-skipping Efficiency
» Development of a general methodology for labelling peptide-morpholino oligonucleotide conjugates using alkyne-azide click chemistry

 
Permissions in this forum:
You cannot reply to topics in this forum